Acanthus Research
Acanthus Research Inc. is a Canadian manufacturer of pharmaceutical reference standards — including drug impurities, metabolites, and stable isotope labeled compounds — serving pharmaceutical, biotechnology, and academic research customers globally via catalog sales and custom synthesis.
- Company typePrivate
- Founded2008
- HeadquartersMississauga, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Acanthus Research does
Acanthus Research Inc. (ARI) is a Mississauga, Ontario-based pharmaceutical reference standards manufacturer founded in 2008. The company produces and sells a catalog of more than 1,000 reference standards spanning drug impurities, drug substances, stable isotope labeled (SIL) compounds (deuterium, 13C, 15N), drug metabolites, and fine research chemicals, all delivered with Certificates of Analysis under a Quality-by-Design system. Technical capabilities include quantitative NMR (qNMR) for direct purity measurement, HPLC and GC analysis, custom organic synthesis, and specialized expertise in stable isotope labeling for LC-MS/MS bioanalytical internal standards and in N-Nitrosamine impurity reference standards addressing FDA 2020 guidance. The catalog also extends to lipid nanoparticle (LNP) components for mRNA vaccine delivery systems.
Revenue is generated through two streams: catalog sales of reference standards and specialty chemicals (quote-based, F.O.B. shipping point, with Net 30 terms for established customers and 100% advance for first-time buyers), and custom synthesis / research project services. Distribution is direct via the company website, email, phone, and international shipping through FedEx and DHL, supplemented by a third-party distributor network. Target customers are primarily pharmaceutical and biotechnology companies conducting drug discovery, bioanalytical method development, pharmacokinetics, and mRNA vaccine development, with secondary sales to academic and government research institutions. Marketing is technical-content driven (ARI Blog, industry conferences including CPhI and the Drug Discovery Strategic Summit).
In 2021, the founders expanded service scope by forming Acanthus Pharma Services Inc. (APSI), a separate CDMO entity focused on custom synthesis and GMP manufacturing, officially launched in March 2022. The two entities share founder ownership and overlap in operations, with APSI providing clinical-stage and GMP support while ARI continues its reference standards and specialty chemicals business. ARI currently operates with 11-50 employees and does not appear to have raised external institutional funding.
Acanthus Research firmographics
Firmographics- Name
- Acanthus Research
- Legal name
- Acanthus Research Inc.
- Website
- https://acanthusresearch.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Acanthus Research Inc. is a Canadian manufacturer of pharmaceutical reference standards — including drug impurities, metabolites, and stable isotope labeled compounds — serving pharmaceutical, biotechnology, and academic research customers globally via catalog sales and custom synthesis.
- Ownership category
- akta.pro rank
Acanthus Research industry classification
Industry- Product category
- Pharmaceutical Reference Standards
- NAICS
- Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (3254)
- SIC
- Medicinal Chemicals & Botanical Products (2833), Industrial Organic Chemicals (2860)
- akta.pro primary industry
- Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)
- akta.pro secondary industries
- Chiral / Asymmetric Synthesis & Complex Chemistry Services (HLAGAHAE), Material Characterization & Spectroscopy (NMR/FTIR/MS) (HLAGADAK)
Keywords
Where Acanthus Research is headquartered
LocationHeadquarters
- HQ city
- Mississauga
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
Acanthus Research business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Operations, Marketing or Sales, Infrastructure
Revenue model
- Reference Standards Catalog Sales: Sale of pharmaceutical reference standards including drug impurities, drug substance standards, stable isotope labeled compounds, drug metabolite standards, and fine research chemicals. Products are sold with Certificate of Analysis. Pricing is quote-based with payment terms of 100% advance for first-time purchases and Net 30 for established customers.
- Custom Synthesis Services: Custom organic synthesis services for specialized pharmaceutical chemistry needs. Quotations are valid for 30 calendar days. Services include custom-designed lipids, isotope-labeled compounds, and specialized pharmaceutical intermediates.
- Specialty Chemicals Sales: Sale of specialty chemicals including labeled specialty chemicals and lipids. Products include phospholipids, fine labeled research chemicals, and custom-designed chemical compounds.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | First-time customer pricing |
| Other | Monthly | Established customer pricing |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels4 records
Acanthus Research product offering
Product offeringCore offering
Acanthus Research manufactures and sells pharmaceutical reference standards, including drug impurities, drug substances, drug metabolites, stable isotope labeled (SIL) compounds, and fine research chemicals. The company also provides custom organic synthesis services for specialized pharmaceutical compounds and quantitative NMR (qNMR) spectroscopy-based purity determination services for customers in the pharmaceutical and biotechnology industries.
Product overview
Acanthus Research Inc. is a Canadian pharmaceutical reference standards manufacturer founded in 2008, offering a comprehensive portfolio of over 1,000 reference standards and specialty chemicals. The core product lines include Drug Impurities Reference Standards, Drug Substance Reference Standards, Drug Metabolites Reference Standards, and Stable Isotope Labeled Reference Standards (both drug substances and metabolites). The company also provides Fine Research Chemicals and Fine Labeled Research Chemicals for specialty applications. Services include Custom Synthesis and Research Projects, with a CDMO spin-off called Acanthus Pharma Services Inc. launched in 2022 for GMP manufacturing. A specialized product line focuses on Lipid Nanoparticle components for mRNA vaccine development. The company also offers qNMR (Quantitative NMR) spectroscopy services for purity determination. All products are backed by a Quality-by-Design System ensuring chemical, enantiomeric, and isotopic purity.
Differentiator
Problem solved
Functional benefit
Products and services
- Drug Impurities Reference Standards High-purity reference standards for drug impurities used in pharmaceutical analysis and quality control, including nitrosamine impurities and genotoxic impurities. These are sold to pharmaceutical companies and contract laboratories for analytical method validation and regulatory compliance testing. Each product is sold with a Certificate of Analysis.
- Drug Substance Reference Standards High-purity reference standards for active pharmaceutical ingredients (APIs) used in analytical method development and validation. Sold to pharmaceutical manufacturers and QC laboratories for use as certified benchmarks in drug substance analysis. Each product ships with a Certificate of Analysis.
- Drug Substance Stable Isotope Labeled Reference Standards Stable isotope labeled (SIL) drug substance reference standards, including deuterium (2H/D), 13C, and 15N labeled compounds, used as internal standards for LC-MS/MS bioanalytical methods. Designed for pharmaceutical and biotech researchers conducting pharmacokinetic and metabolism studies, with isotope labels positioned on non-exchangeable sites for optimal performance.
- Drug Metabolites Reference Standards Reference standards for drug metabolites used in metabolism studies and pharmacokinetic research. Sold to pharmaceutical R&D teams and academic researchers conducting ADME (absorption, distribution, metabolism, excretion) investigations and metabolic pathway characterization.
- Drug Metabolites Stable Isotope Labeled Reference Standards Stable isotope labeled drug metabolite reference standards for use in bioanalytical methods and metabolic studies. Designed for pharmaceutical and biotech researchers requiring isotope-labeled metabolite references for LC-MS/MS quantification in metabolism and pharmacokinetic research.
- Fine Labeled Research Chemicals Labeled research chemicals with isotopic enrichment for analytical and research applications. Targeted at academic institutions, pharmaceutical researchers, and analytical chemistry laboratories requiring specialty isotopically enriched compounds.
- Fine Research Chemicals High-purity specialty chemicals and building blocks for pharmaceutical research and development. Sold to pharmaceutical R&D and academic research customers requiring specialty chemical intermediates and building blocks.
- Lipid Nanoparticle (LNP) Components for mRNA Vaccines Custom synthesized lipid components for lipid nanoparticle delivery systems used in mRNA vaccine development, including ionizable cationic lipids, neutral phospholipids, PEG-conjugated lipids, and cholesterol. Sold to biotechnology companies and pharmaceutical researchers developing mRNA-based vaccines and therapeutics.
- Custom Synthesis Services Custom organic synthesis services for producing novel compounds, including custom-designed lipids, to support developmental and commercial pharmaceutical products. Services are offered to pharmaceutical and biotechnology clients requiring specialized compounds not available commercially, with quotations valid for 30 calendar days.
- Research Projects Collaborative research project services for pharmaceutical and biotechnology clients. Engagements typically involve consultative collaboration on specialized pharmaceutical chemistry problems requiring custom synthesis and analytical chemistry expertise.
- Quantitative NMR (qNMR) Spectroscopy Services qNMR-based assay determination and purity measurement services for pharmaceutical reference standards, offering direct purity measurements as an alternative to mass balance methods. Services provide direct measurement of analyte concentration, avoid impurity response dependencies in HPLC, and use reduced solvents. Available to pharmaceutical manufacturers and reference standard customers requiring high-accuracy purity characterization.
Companies that use Acanthus Research
Customer profileSegments3 records
Ideal customer profiles3 records
Acanthus Research technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Acanthus Research partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Acanthus Pharma Services Inc.coreIn 2021, Acanthus Research Inc. (ARI) founders expanded service offerings by forming a new company, Acanthus Pharma Services Inc. (APSI), focusing on custom synthesis requests and GMP manufacturing. APSI operates as a light-framework CDMO organization providing nimble and flexible support for pharmaceutical and biotech clients navigating clinical environments. APSI initially operated from ARI offices at 2395 Speakman Dr until facility renovations at 755 Queensway East were completed in late 2022.
Scale indicators3 records
Recent moves7 records
Expansion highlights5 records
Acanthus Research competitors and assessment
Company assessmentDirect peers
- Clearsynth: India-based manufacturer of pharmaceutical reference standards, impurities, and stable isotope labeled compounds with custom synthesis services. Comparable offering across Acanthus's core product lines and a direct competitor for global pharma QC accounts.
- Cayman Chemical: US-based supplier of biochemical reference standards, drug metabolites, impurities, and research chemicals to pharma, academic, and government labs. Comparable product portfolio (impurities, metabolites, specialty chemicals) and similar custom synthesis service offering.
- Cambridge Isotope Laboratories: Global leader in stable isotope labeled compounds (deuterium, 13C, 15N) used as internal standards and research chemicals. Directly comparable to Acanthus's stable isotope labeled drug substance and metabolite reference standard lines.
- Syncom (Synthese Communicatie): Dutch contract manufacturer specializing in custom synthesis, reference standards, impurities, and labeled compounds for pharma. Comparable custom synthesis and reference standards offering with similar niche positioning.
- Santa Cruz Biotechnology: Supplier of biochemical and pharmaceutical reference standards, antibodies, and research reagents for life science research. Comparable in catalog breadth of research-grade standards and specialty reagents.
- CDN Isotopes: Canadian supplier of stable isotope labeled compounds (13C, 15N, 18O, D) and pharmaceutical reference standards. Closely comparable niche player in the SIL standards space that Acanthus also serves.
- Cerilliant (Sigma-Aldrich / Merck KGaA): Specialty manufacturer of certified reference standards for forensic, clinical, pharmaceutical, and environmental analysis, including drug impurities, metabolites, and stable isotope labeled standards. Direct overlap with Acanthus's drug impurity and metabolite reference standard lines.
- Toronto Research Chemicals: Canadian manufacturer of pharmaceutical reference standards, impurities, metabolites, and stable isotope labeled compounds. Most directly comparable peer given overlapping product lines, Canadian base, and similar customer base of pharma QC and R&D labs.
Broad incumbents
- LGC Standards: European reference materials and standards provider with a broad pharmaceutical reference standards catalog. Larger, multi-category incumbent competing with Acanthus on certified drug impurity and API standards, particularly in Europe.
- Sigma-Aldrich (Merck KGaA / MilliporeSigma): Largest broad-line supplier of analytical reference standards, fine chemicals, and reagents used in pharmaceutical R&D and QC. Competes with Acanthus across most catalog SKUs as a broader incumbent with global scale.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Acanthus Research social profiles
Digital presenceAcanthus Research financial estimates
Financial estimateRevenue estimate
Valuation estimate
Acanthus Research leadership team
Management profileNumber of profiles
Profiles1 record
Acanthus Research subsidiaries and ownership
Company hierarchySubsidiaries1 record
Acanthus Research funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Acanthus Research M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Acanthus Research
What does Acanthus Research do?
Acanthus Research manufactures and sells pharmaceutical reference standards, including drug impurities, drug substances, drug metabolites, stable isotope labeled (SIL) compounds, and fine research chemicals. The company also provides custom organic synthesis services for specialized pharmaceutical compounds and quantitative NMR (qNMR) spectroscopy-based purity determination services for customers in the pharmaceutical and biotechnology industries.
Is Acanthus Research a public or private company?
Acanthus Research is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Acanthus Research founded?
Acanthus Research was founded in 2008. It employs 11 to 50 people.
Where is Acanthus Research based?
Acanthus Research is headquartered in Mississauga, Canada, in the North America region.
How does Acanthus Research make money?
Three revenue lines are on record. Reference Standards Catalog Sales are the primary driver. The others are custom Synthesis Services and specialty Chemicals Sales.
Who are Acanthus Research's main competitors?
Direct peers on record are Clearsynth, Cayman Chemical, Cambridge Isotope Laboratories, Syncom (Synthese Communicatie), Santa Cruz Biotechnology, CDN Isotopes, Cerilliant (Sigma-Aldrich / Merck KGaA) and Toronto Research Chemicals. Broad incumbents are LGC Standards and Sigma-Aldrich (Merck KGaA / MilliporeSigma).
Does Acanthus Research have an API?
No public API is recorded for Acanthus Research.
What industry is Acanthus Research in?
Acanthus Research's product category is Pharmaceutical Reference Standards. Its primary akta.pro industry code is HLAGAHAG, Impurity / Reference Standard Synthesis & Characterization, with a secondary code of HLAGAHAE, Chiral / Asymmetric Synthesis & Complex Chemistry Services. Its NAICS code is 325411 and its SIC code is 2833.